Interwell Health
Waltham, US · Founded 2019 · Delaware LLC · 1 known investors
Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.
Founders & leadership
GH

George HartExecutive
KA
Karen A. GledhillExecutive
TK
Terry KetchersidExecutive
AV
Alex ValleNamed on SEC filing
CT
Carney TaylorNamed on SEC filing
TB
Tracy BahlNamed on SEC filing
CZ
Charles ZachemNamed on SEC filing
GL
Gina LoftenNamed on SEC filing
AA
Alex AzarNamed on SEC filing
RS
Robert SepuchaNamed on SEC filing
JA
John ArlottaNamed on SEC filing
Board
EM
Eric MaaskeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$84.4M disclosed across 3 rounds · 2019–2023
▶$18.3MraisedMar 2023 · 27 investors · Other Health CareRule 506(c)
▶$18.3MraisedMar 2023 · 27 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Alex ValleDirector
- David PollackExecutive Officer
- Carney TaylorDirector
- Tracy BahlDirector
- Charles ZachemDirector
- Gina LoftenDirector
- Alex AzarDirector
- Robert SepuchaExecutive Officer, Director
- John ArlottaDirector
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- Minimum investment
- $100K
- First sale
- Mar 2023
- Incorporated
- Limited Partnership, Delaware, 2022
- Federal exemptions
- 06c
▶$46.1MraisedMay 2021 · 53 investors · Other Health CareRule 506(b)
▶$46.1MraisedMay 2021 · 53 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan PriceDirector
- KIm SonnenDirector
- Manish TannaDirector
- Ruben VelezDirector
- Dylan SteerDirector
- Ashish SoniDirector
- Ben HippenDirector
- George HartExecutive Officer
- Karen A. GledhillExecutive Officer, Director
- David PollackDirector
- Terry KetchersidExecutive Officer
- Eric MaaskeDirector
- Jeffrey L. HymesDirector
- William J. ValleDirector
- Offering amount
- $46.1M
- Amount sold
- $46.1M
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
▶$20MraisedApr 2020 · 17 investors · Other Health CareRule 506(b)
▶$20MraisedApr 2020 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- KIm SonnenExecutive Officer
- Jeffrey L. HymesExecutive Officer
- Karen A. GledhillExecutive Officer
- David PollackExecutive Officer
- William J. ValleExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- Minimum investment
- $250K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Interwell Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Interwell Health do?
- Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.
- Who are Interwell Health's investors?
- Interwell Health's investors include Oak HC/FT.
- How much funding has Interwell Health raised?
- Interwell Health has disclosed $84.4M raised across 3 rounds.
- Where is Interwell Health headquartered?
- Interwell Health is headquartered in Waltham, US.